Repros Therapeutics, Inc. (RPRX)

[hptaxis]

I agree that NBIX share price is taking a beating, or worse. I do not even pretend to know the reasoning behind the ups and downs of stock prices, including and particularly RPRX.

But I would venture that another cause is not that NBIX did not reach significance on primary endpoints, but that the significance was not as robust as expected or wanted. Further, NBIX is blunt about the endpoints that will be required by the FDA. Contrast this with RPRX, which is using a modified BB scale not acceptable to the FDA. The FDA no longer accepts or uses the physician component!

As far as the data, I disagree with your conclusion, but the argument is for a later post - and to be argued with respect to RPRX.